Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Johnson and Johnson
Merck
Baxter
Boehringer Ingelheim

Last Updated: October 2, 2022

Investigational Drug Information for Dutogliptin


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for Dutogliptin?

Dutogliptin is an investigational drug.

There have been 10 clinical trials for Dutogliptin. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2009.

The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Myocardial Ischemia. The leading clinical trial sponsors are Phenomix, Forest Laboratories, and Recardio, Inc.

Recent Clinical Trials for Dutogliptin
TitleSponsorPhase
Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial InfarctionRecardio, Inc.Phase 2
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone AlonePhenomixPhase 3
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone AloneForest LaboratoriesPhase 3

See all Dutogliptin clinical trials

Clinical Trial Summary for Dutogliptin

Top disease conditions for Dutogliptin
Top clinical trial sponsors for Dutogliptin

See all Dutogliptin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Johnson and Johnson
Merck
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.